ACTIVE VERSUS PASSIVE PHARMACOVIGILANCE- ADALIMUMAB-RELATED INFECTIONS REPORTED IN OBSERVATIONAL STUDIES COMPARED WITH THE FDA’S ADVERSE EVENT REPORTING SYSTEM CASES

Author(s)

Chen C, Borrego M, Roberts M, Raisch DW
University of New Mexico College of Pharmacy, Albuquerque, NM, USA

OBJECTIVES:  To compare adalimumab-related infections reported in observational studies to those reported in the U.S. FDA’s Adverse Event Reporting System (FAERS). METHODS: Using MedDRA® preferred terms (PTs), infection and infestation cases in FAERS with adalimumab as the primary suspect drug were extracted though EvidexTM

Conference/Value in Health Info

2017-05, ISPOR 2017, Boston, MA, USA

Value in Health, Vol. 20, No. 5 (May 2017)

Code

PIN2

Topic

Epidemiology & Public Health

Topic Subcategory

Safety & Pharmacoepidemiology

Disease

Infectious Disease (non-vaccine), Multiple Diseases, Systemic Disorders/Conditions

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×